192 related articles for article (PubMed ID: 7636270)
1. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response.
Kim J; Modlin RL; Moy RL; Dubinett SM; McHugh T; Nickoloff BJ; Uyemura K
J Immunol; 1995 Aug; 155(4):2240-7. PubMed ID: 7636270
[TBL] [Abstract][Full Text] [Related]
2. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes.
Wang Q; Redovan C; Tubbs R; Olencki T; Klein E; Kudoh S; Finke J; Bukowski RM
Int J Cancer; 1995 Jun; 61(6):780-5. PubMed ID: 7790111
[TBL] [Abstract][Full Text] [Related]
3. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.
Kooi S; Freedman RS; Rodriguez-Villanueva J; Platsoucas CD
Lymphokine Cytokine Res; 1993 Dec; 12(6):429-37. PubMed ID: 8123759
[TBL] [Abstract][Full Text] [Related]
4. Local immune response in cutaneous basal cell carcinoma.
Omland SH
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975891
[TBL] [Abstract][Full Text] [Related]
5. Characteristic cytokine generation patterns in cancer cells and infiltrating lymphocytes in oral squamous cell carcinomas and the influence of chemoradiation combined with immunotherapy on these patterns.
Yamamoto T; Kimura T; Ueta E; Tatemoto Y; Osaki T
Oncology; 2003; 64(4):407-15. PubMed ID: 12759539
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.
Nash MA; Lenzi R; Edwards CL; Kavanagh JJ; Kudelka AP; Verschraegen CF; Platsoucas CD; Freedman RS
Clin Exp Immunol; 1998 May; 112(2):172-80. PubMed ID: 9649178
[TBL] [Abstract][Full Text] [Related]
7. Local expression of antiinflammatory cytokines in cancer.
Yamamura M; Modlin RL; Ohmen JD; Moy RL
J Clin Invest; 1993 Mar; 91(3):1005-10. PubMed ID: 8450029
[TBL] [Abstract][Full Text] [Related]
8. The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival.
Barth RJ; Camp BJ; Martuscello TA; Dain BJ; Memoli VA
Cancer; 1996 Sep; 78(6):1168-78. PubMed ID: 8826937
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12.
Ulchaker J; Panuto J; Rayman P; Novick A; Elson P; Tubbs R; Finke JH; Bukowski RM
J Immunother; 1999 Jan; 22(1):71-9. PubMed ID: 9924702
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10?
Kooy AJ; Prens EP; Van Heukelum A; Vuzevski VD; Van Joost T; Tank B
J Pathol; 1999 Feb; 187(3):351-7. PubMed ID: 10398091
[TBL] [Abstract][Full Text] [Related]
11. Toll-Like Receptor 7 Staining in Malignant Epithelial Tumors.
Franz R; Ritter N; Hein R; Biedermann T; Al-Sisi M; Eyerich K; Garzorz-Stark N; Andres C
Am J Dermatopathol; 2017 Oct; 39(10):742-746. PubMed ID: 28857981
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
13. Cytokine concentrations in basal cell carcinomas of different histological types and localization.
Elamin I; Zecević RD; Vojvodić D; Medenica L; Pavlović MD
Acta Dermatovenerol Alp Pannonica Adriat; 2008 Jun; 17(2):55-9. PubMed ID: 18709290
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer.
Nardinocchi L; Sonego G; Passarelli F; Avitabile S; Scarponi C; Failla CM; Simoni S; Albanesi C; Cavani A
Eur J Immunol; 2015 Mar; 45(3):922-31. PubMed ID: 25487261
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients.
Asselin-Paturel C; Echchakir H; Carayol G; Gay F; Opolon P; Grunenwald D; Chouaib S; Mami-Chouaib F
Int J Cancer; 1998 Jul; 77(1):7-12. PubMed ID: 9639386
[TBL] [Abstract][Full Text] [Related]
16. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating lymphocytes isolated from a Ki-1-positive large cell lymphoma of the skin. Phenotypic characterization and analysis of cytokine secretion.
Reinhold U; Abken H; Kukel S; Goeden B; Uerlich M; Neumann U; Kreysel HW
Cancer; 1991 Nov; 68(10):2155-60. PubMed ID: 1655203
[TBL] [Abstract][Full Text] [Related]
18. Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma.
Nakagomi H; Pisa P; Pisa EK; Yamamoto Y; Halapi E; Backlin K; Juhlin C; Kiessling R
Int J Cancer; 1995 Nov; 63(3):366-71. PubMed ID: 7591233
[TBL] [Abstract][Full Text] [Related]
19. Cancer-testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas.
Walter A; Barysch MJ; Behnke S; Dziunycz P; Schmid B; Ritter E; Gnjatic S; Kristiansen G; Moch H; Knuth A; Dummer R; van den Broek M
Clin Cancer Res; 2010 Jul; 16(14):3562-70. PubMed ID: 20519358
[TBL] [Abstract][Full Text] [Related]
20. Selective accumulation of T cells according to T-cell receptor V beta gene usage in skin cancer.
Ohmen JD; Moy RL; Zovich D; Lieberman A; Wyzykowski RJ; Sullivan L; Modlin RL; Uyemura K
J Invest Dermatol; 1994 Dec; 103(6):751-7. PubMed ID: 7798611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
